Transcription of Injection: 150 mg/mL solution in a single-use …
{{id}} {{{paragraph}}}
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use COSENTYX safely and effectively. See full prescribing information for COSENTYX. COSENTYX (secukinumab) injection, for subcutaneous use COSENTYX (secukinumab) for injection, for subcutaneous use Initial Approval: 2015 -----------------------------INDICATIONS AND USAGE-------------------------- COSENTYX is a human interleukin-17A antagonist indicated for the treatment of: moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy ( ) adults with active psoriatic arthritis (PsA) ( ) adults with active ankylosing spondylitis (AS) ( ) -----------------------DOSAGE AND ADMINISTRATION----------------------- Plaque Psoriasis Recommended dosage is 300 mg by subcutaneous injection at Weeks 0, 1, 2, 3, and 4 followed by 300 mg every 4 weeks.
The removable cap of the COSENTYX Sensoready pen and the COSENTYX prefilled syringe contains natural rubber latex and should …
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}